Analysts’ Viewpoint on Market Scenario
Rise in alcohol and tobacco consumption among the populace is leading to a surge in cases of lung injuries, which in turn is projected to drive the global acute lung injury treatment market size. Air pollution and obesity can also lead to acute and chronic lung injuries.
Surge in the geriatric population is likely to offer lucrative growth opportunities for vendors in the industry. Vendors are focused on the development, production, and distribution of novel therapies to increase their global acute lung injury treatment market share.
Acute Lung Injury (ALI) is a serious medical condition in which lung tissues become inflamed and damaged, resulting in breathing difficulties and low blood oxygen levels. Infections, chemical exposure, and trauma are major factors that can cause ALI. The condition can progress to a more severe disease known as Acute Respiratory Distress Syndrome (ARDS), which has a high mortality rate of around 40% with the current standard of care.
Air pollution is linked to an increased risk of respiratory infections, asthma, and chronic obstructive pulmonary disease (COPD), which can lead to ALI. Elderly people are more susceptible to ALI due to a decline in lung function in the age group. The ongoing COVID-19 pandemic has led to a significant increase in the number of ALI cases, particularly in patients with severe COVID-19 infections.
An increase in the incidence of infections, such as influenza and pneumonia, can lead to high cases of ALI. Various studies are exploring the use of biological agents, such as surfactant replacement therapy and anti-inflammatory drugs, for the treatment of ALI.
The development of advanced technologies, such as mechanical ventilation, oxygen therapy, and extracorporeal membrane oxygenation (ECMO), has improved the survival rate of patients with ALI. ECMO is an emerging treatment option for ALI that involves oxygenating the blood outside the body and subsequently returning it to the patient. Thus, R&D of new technologies and a rise in focus on improving patient outcomes are projected to aid in the acute lung injury treatment market growth in the near future.
Smoking is a major risk factor for ALI and COPD. Nicotine present in cigarettes damages the lungs and can lead to inflammation and scarring. This can make it harder for the lungs to function properly, leading to a high risk of ALI and COPD. Thus, the surge in the number of smokers is projected to augment market progress in the next few years.
E-cigarettes and vaping products are gaining traction among the populace. These products have been linked to a rise in cases of ALI. According to the Centers for Disease Control and Prevention (CDC), tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products, particularly from informal sources such as friends, family, or in-person or online dealers, are linked to the majority of E-cigarette or Vaping Use-associated Lung Injury (EVALI) cases. Additionally, in February 2020, the CDC received reports of 2,807 hospitalized cases of EVLAI.
Aerosols produced by e-cigarettes contain various chemicals, including nicotine, flavorings, and solvents, which can be inhaled deep into the lungs. These chemicals can cause irritation and inflammation, leading to ALI symptoms such as shortness of breath, chest pain, and coughing. Moreover, some e-cigarettes have been found to contain harmful substances, such as heavy metals and diacetyl, which can further increase the risk of ALI. Therefore, growth in the usage of e-cigarettes and vaping products is likely to fuel the acute lung injury treatment market statistics in the near future.
Aging leads to a decline in lung function, making older adults more susceptible to ALI. Elderly people witness a decrease in lung elasticity, an increase in inflammation, and a decline in the strength of the immune system. These factors make older adults more susceptible to infections and inflammation.
COPD and heart disease are common diseases in geriatric people. Consumption of multiple medications also increases the risk of ALI in this age group. Therefore, the surge in the geriatric population is expected to augment market dynamics in the next few years.
According to the latest acute lung injury treatment market insights, the mechanical ventilation therapy segment is expected to hold the largest share during the forecast period. Mechanical ventilation is the first line of treatment for ALI. It effectively improves oxygenation and reduces the workload of the lungs. Mechanical ventilation can be adjusted to the patient's specific needs and can be utilized in combination with other therapies such as inhaled medications and ECMO.
The hospital end-user segment is anticipated to dominate the acute lung injury treatment industry during the forecast period. ALI is a serious medical condition that requires prompt and specialized care, which is typically provided in a hospital setting. Patients generally require a month of hospitalization for the proper treatment and management of ALI.
Hospitals have access to specialized equipment and technologies, such as mechanical ventilators, ECMO machines, and High-frequency Oscillatory Ventilators (HFOV), which are essential for the treatment of ALI. Additionally, hospitals have a team of trained healthcare professionals, including pulmonologists, critical care specialists, and respiratory therapists.
According to the latest acute lung injury treatment market forecast, North America is estimated to hold the largest share during the forecast period. An increase in the adoption of vaping and the high prevalence of ALI are expected to propel market revenue in the region in the near future. According to the CDC, about 1 in 20 people in the U.S., several of whom are middle and high school kids, use electronic cigarettes or vapes.
R&D of new therapies for the treatment of ALI is likely to increase the market share in Europe in the next few years. The rise in the geriatric population, growth in air pollution, and surge in cases of ALI and COVID-19 are projected to drive the demand for ALI treatment in Asia Pacific in the near future. A rise in the number of clinical trials and an increase in investment in the R&D of new therapies are estimated to drive the market size in Latin America during the forecast period.
The global industry is fragmented with the presence of a large number of hospitals. Key players operating in the industry include Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, and Aster Hospitals.
The acute lung injury treatment market research report profiles major vendors based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 3.0 Bn |
|
Forecast Value in 2031 |
More than US$ 3.6 Bn |
|
CAGR - 2022–2031 |
3.0% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
.Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 3.0 Bn in 2021.
It is projected to reach a value of more than US$ 3.6 Bn by the end of 2031.
It is anticipated to be 3.0% from 2022 to 2031.
The hospitals segment held more than 60.0% share in 2021.
North America is expected to account for largest share from 2022 to 2031.
Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, and Aster Hospitals.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Acute Lung Injury Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Acute Lung Injury Treatment Market Analysis and Forecast, 2017 - 2031
4.4.1. Market Revenue Projection (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Therapy
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapy, 2017 - 2031
6.3.1. Mechanical Ventilation
6.3.2. Pharmacotherapy
6.3.3. Fluid Management
6.3.4. Others
6.4. Market Attractiveness, by Therapy
7. Global Acute Lung Injury Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017 - 2031
7.3.1. Hospitals
7.3.2. Specialty Centers
7.3.3. Others
7.4. Market Attractiveness, by End-user
8. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Acute Lung Injury Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Therapy, 2017 - 2031
9.2.1. Mechanical Ventilation
9.2.2. Pharmacotherapy
9.2.3. Fluid Management
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017 - 2031
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017 - 2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Therapy
9.5.2. By End-user
9.5.3. By Country
10. Europe Acute Lung Injury Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Therapy, 2017 - 2031
10.2.1. Mechanical Ventilation
10.2.2. Pharmacotherapy
10.2.3. Fluid Management
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017 - 2031
10.3.1. Hospitals
10.3.2. Specialty Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Therapy
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Acute Lung Injury Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapy, 2017 - 2031
11.2.1. Mechanical Ventilation
11.2.2. Pharmacotherapy
11.2.3. Fluid Management
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017 - 2031
11.3.1. Hospitals
11.3.2. Specialty Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Therapy
11.5.2. By End-user
11.5.3. By Country/sub-region
12. Latin America Acute Lung Injury Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy, 2017 - 2031
12.2.1. Mechanical Ventilation
12.2.2. Pharmacotherapy
12.2.3. Fluid Management
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017 - 2031
12.3.1. Hospitals
12.3.2. Specialty Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Therapy
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Acute Lung Injury Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy, 2017 - 2031
13.2.1. Mechanical Ventilation
13.2.2. Pharmacotherapy
13.2.3. Fluid Management
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017 - 2031
13.3.1. Hospitals
13.3.2. Specialty Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Therapy
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis By Company (2021)
14.3. Company Profiles
14.3.1. Mayo Clinic
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Business Strategies
14.3.1.5. Recent Developments
14.3.2. Johns Hopkins Hospital
14.3.2.1. Company Overview
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. Business Strategies
14.3.2.5. Recent Developments
14.3.3. Cleveland Clinic
14.3.3.1. Company Overview
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. Business Strategies
14.3.3.5. Recent Developments
14.3.4. Great Ormond Street Hospital
14.3.4.1. Company Overview
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. Business Strategies
14.3.4.5. Recent Developments
14.3.5. Apollo Hospitals
14.3.5.1. Company Overview
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. Business Strategies
14.3.5.5. Recent Developments
14.3.6. Tokyo Medical University Hospital
14.3.6.1. Company Overview
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. Business Strategies
14.3.6.5. Recent Developments
14.3.7. The Prince Charles Hospital
14.3.7.1. Company Overview
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. Business Strategies
14.3.7.5. Recent Developments
14.3.8. Helios Hospital
14.3.8.1. Company Overview
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. Business Strategies
14.3.8.5. Recent Developments
14.3.9. Aster Hospitals
14.3.9.1. Company Overview
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. Business Strategies
14.3.9.5. Recent Developments
List of Tables
Table 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 02: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 06: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 07: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 08: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 09: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 10: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 12: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 13: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 15: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 16: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031
Table 18: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
List of Figures
Figure 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Acute Lung Injury Treatment Market Value Share, by Therapy, 2021
Figure 04: Acute Lung Injury Treatment Market Value Share, by End-user, 2021
Figure 05: Acute Lung Injury Treatment Market Value Share, by Region, 2021
Figure 06: Global Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 07: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 08: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Mechanical Ventilation, 2017‒2031
Figure 09: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Pharmacotherapy, 2017‒2031
Figure 10: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Fluid Management, 2017‒2031
Figure 12: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017‒2031
Figure 13: Global Acute Lung Injury Treatment Market Value Share Analysis, by End-user 2021 and 2031
Figure 14: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user 2022–2031
Figure 15: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 16: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Specialty Centers, 2017–2031
Figure 17: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017–2031
Figure 18: Global Acute Lung Injury Treatment Market Value Share Analysis, by Region, 2021 and 2031
Figure 19: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Region, 2022–2031
Figure 20: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 21: North America Acute Lung Injury Treatment Market Value Share Analysis, by Country, 2021 and 2031
Figure 22: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country, 2022–2031
Figure 23: North America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 24: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy 2022–2031
Figure 25: North America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
Figure 26: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 27: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 28: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 29: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 31: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 32: Europe Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
Figure 33: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 34: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 35: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 36: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 37: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 38: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 39: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 41: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 42: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 43: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 44: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 45: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 46: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
Figure 47: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 48: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 49: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 50: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 51: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 52: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 53: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
Figure 54: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Company Share Analysis
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Acute Lung Injury Treatment Market
*86 figures and 60 tables includes